Predictmedix AI Inc - 2025 Year End Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company") concludes 2025 having delivered a year of disciplined execution across technology development, global investor engagement, and strategic advancement—positioning the Company for a pivotal growth phase in 2026 at the convergence of artificial intelligence, quantum-inspired computation, and digital healthcare. Throughout 2025, Predictmedix AI...
2025-12-17 7:00 AM EST
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, is pleased to announce that it has successfully closed the final tranche of its non-brokered private placement (the "Offering"). In this final tranche, the Company issued 3,050,000 units ("Units") at a price of $0.05 per Unit, for gross proceeds of $152,500, bringing the total...
2025-12-05 5:02 PM EST
Predictmedix AI Announces Closing of $460,150 First Tranche
Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, is pleased to announce the successful closing of the first tranche of its non-brokered private placement. The Company issued 9,203,000 units ("Units") at an issue price of $0.05 per Unit, raising gross proceeds of $460,150. Notably, $60,000 of the tranche was subscribed by...
2025-11-17 5:02 PM EST
Predictmedix AI Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announces a proposed non brokered private placement. The Company intends to issue (the "Offering") of up to 18,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$900,000. Each Unit will be comprised of one common...
2025-10-20 7:05 AM EDT
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announced the launch of its Clinical-Trial AI Platform, an AI-driven solution intended to help pharmaceutical sponsors and contract research organizations (CROs) model, plan, and adapt clinical trials more efficiently. A Digital Brain for Clinical Trials Built on patented...
2025-10-01 12:01 AM EDT